New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain immunocompromised people, researchers at McGill University say.
The International Journal of Whole Person Care
Special issue on Vulnerability/wholepersoncareCategory: Alumni
Medicine and Health Sciences
School of Nursing
Students
Lung cancer is the leading cause of cancer-related deaths in Quebec and Canada, killing more individuals than prostate, colon and breast cancers combined. Thanks to tissue samples from almost 500...
New funding of $5.1 million from the Canada Foundation for Innovation (CFI), announced today by the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will help...
When an Indigenous patient receiving treatment at the MUHC refused to eat, McGill MScA candidate Manveen Sethi was enlisted to find an authentic recipe for Bannock bread, a traditional Indigenous...
Despite high hopes, a new pan-Canadian study published today in The BMJ suggests that ciclesonide—an inhaled and nasal steroid drug commonly used for asthma and rhinitis—won’t be the treatment to...
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
Source: RI-MUHC
RSS